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Introduction {#sec005}
============

Worldwide, approximately 285 million people have impaired vision due to either eye diseases or uncorrected refractive errors (RE). \[[@pone.0231034.ref001]\] The latter alone affect 122 million people whose full vision could be restored with prescription glasses \[[@pone.0231034.ref001]\], 90% of whom live in low- and middle-income countries. \[[@pone.0231034.ref002]\] The World Health Organization has stated that individuals and families are frequently pushed into a cycle of poverty because of their inability to see well. \[[@pone.0231034.ref002]\]

In Brazil, uncorrected RE and cataract are the most common causes of impaired vision \[[@pone.0231034.ref003]--[@pone.0231034.ref005]\], followed by diabetic retinopathy and glaucoma. \[[@pone.0231034.ref005]\] These conditions can be effectively corrected or treated, and early detection may reduce disease burden and improve clinical outcomes. However, provision of access to secondary and tertiary care in the Brazilian public health system (*Sistema Único de Saúde*--SUS, Unified Health System) is still challenging. \[[@pone.0231034.ref006]\] Limited access results in long wait times for specialty care, underdiagnosis of eye conditions, and treatment delays.

*TeleOftalmo* is a telemedicine initiative for the Unified Health System that supports primary care with ophthalmologic diagnoses at a distance. Primary care physicians (PCP) can request a comprehensive "tele-eye exam" for their patients. Ophthalmologists working remotely examine patients' eyes in synchronous fashion, and then send a tele-eye report to the requesting PCP, who is in charge of prescriptions and other clinical management. The Brazilian legal framework does not allow physicians to provide prescriptions through telemedicine \[[@pone.0231034.ref007]\]; hence, PCPs play the central role in delivering direct care with the telemedicine support. Additional information on the *TeleOftalmo* project is presented in [Box 1](#pone.0231034.box001){ref-type="boxed-text"}.

Box 1 Main features of the *TeleOftalmo* project {#sec006}
------------------------------------------------

10.1371/journal.pone.0231034.t001
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  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  • Conceived by TelessaúdeRS-UFRGS, a university telehealth center that creates and evaluates innovative telemedicine applications to overcome public healthcare challenges. \[[@pone.0231034.ref008]\]
  • Headquarters located in the state capital, Porto Alegre, equipped with four private workstations for ophthalmologists;
  • Eight remote units at primary or secondary care centers across the state;
  • Trained nurses and technicians work at remote units under the supervision of a local general practitioner;
  • Remote units and headquarters are networked through a high-speed, dedicated line;
  • Current offer is 1,500--1,700 tele-eye exams per month;
  • Each tele-eye exam covers visual acuity, refraction test, anterior segment imaging, non-dilated fundus examination, and intraocular pressure measurement;
  • The ophthalmologist's report is sent to the Primary Care Physician through a secure, online platform;
  • Main funding provided by the Brazilian Ministry of Health trough PROADI-SUS, a national program that sponsors Unified Health System development.
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The purpose of this study is to determine whether the *TeleOftalmo* strategy can obviate the need for specialty appointments by solving common eye conditions in primary care facilities. The rationale of addressing eye problems by means of telemedicine at the primary level of care is to promote a more effective use of specialty centers and, expectedly, to reduce mean waiting time for those needing treatments provided only at the tertiary level.

Materials and methods {#sec007}
=====================

Settings {#sec008}
--------

Rio Grande do Sul, with a population of about 11 million, is the southernmost state of Brazil. [Fig 1](#pone.0231034.g001){ref-type="fig"} displays a map of the state with the distribution of *TeleOftalmo* headquarters and remote units across the territory. The locations of remote units are defined according to population density and to existing health system regions and network.

![Map of Rio Grande do Sul state.\
*TeleOftalmo* units are located in the following municipalities: Porto Alegre (headquarters and two remote units), Farroupilha, Passo Fundo, Santa Rosa, Santiago, Santa Cruz do Sul, and Pelotas (one remote unit each).](pone.0231034.g001){#pone.0231034.g001}

Patients {#sec009}
--------

Patients over the age of 7 were eligible for *TeleOftalmo* if they presented to a primary care facility with one or more of the following: complaint of diminished vision; known or suspected RE; strabismus; disorders of the eyelids; conjunctival disorders; cataract without previous indication for surgery; or need for diabetic retinopathy screening. The exclusion criteria were: red eye or vision loss with acute onset; previously diagnosed eye disease requiring prompt medical or surgical treatment, such as uveitis, glaucoma, retinal disease, lacrimal drainage system disorder, orbital disease, and others; and cognitive impairment that would prevent adequate data collection.

Study design and outcomes {#sec010}
-------------------------

We carried out a cross-sectional evaluation of all assessment reports issued during the first 14 months of *TeleOftalmo* operation.

The main outcome was the resolution capacity of the *TeleOftalmo* strategy, defined as the ability to fully address patients' eye complaints, under the following conditions:

1.  The patient did not present with an eye condition requiring referral to a specialty center;

2.  If the patient presented an eye condition, this condition was amenable to treatment and follow-up at the primary care setting, according to Rio Grande do Sul State Department of Health clinical protocols \[[@pone.0231034.ref009]\]; and

3.  The respective tele-eye report did not recommend any further eye examination.

For purposes of analysis, patients were classified into the following age groups: children (age \<12 years), teenagers (13--17 years), young adults (18--39 years), adults (40--64 years), and older adults (≥65 years). We also compared resolution capacity in diabetic and non-diabetic patients. Finally, we evaluated the prevalence of each telediagnosed eye condition and compared resolution capacity across conditions.

The *TeleOftalmo* system {#sec011}
------------------------

Our information technology (IT) team developed and implemented the following solutions for this project:

1.  Telehealth platform: secure online platform that connects primary care services and the telehealth center (available at:[www.plataformatelessaude.ufrgs.br](http://www.plataformatelessaude.ufrgs.br/)). We developed a special module within this platform that includes electronic requests for telemedicine evaluations, scheduling, patient information, health data acquisition and storage, interpretation of data by consultant ophthalmologist, generation of tele-eye reports, and auditing activities. The module was specially designed to fulfill ophthalmology requirements; \[[@pone.0231034.ref010]\]

2.  Telepresence system: videoconferencing system that uses remotely operated robotic cameras and live video streaming. The remote ophthalmologist controls all camera functions such as rotation and zoom. Camera's high resolution allows the remote ophthalmologist to see fine details in the patient's eyes, such as eye movements when testing extraocular motor function and pupillary size when testing pupillary reflexes. Live videoconferencing makes possible to perform interactive tests with patients such as subjective refraction;

3.  Interoperability: The telehealth platform, a central Digital Imaging and Communication in Medicine (DICOM) server, and the diagnostic devices were integrated. All transfers of patient-identifying information from the platform to each device occurs through the server. Likewise, eye examination data acquired by the devices are readily stored in the server and made available at the consultant ophthalmologists' review workstations;

4.  Medical equipment connected through a closed network: by means of networking remote units' equipment and ophthalmologists' workstations, we made possible to operate medical equipment from a distance. This includes digital refractors and visual acuity screens.

Workflow {#sec012}
--------

The PCP accesses the platform to request a teleophthalmology diagnostic. If the patient meets the enrollment criteria, the tele-eye exam is scheduled at the remote unit nearest the patient's home.

At the remote unit, nurses and technicians follow a detailed, predefined data acquisition workflow. The exams are: visual acuity; automatic refractometry; slit-lamp images of the eye's anterior segment; non-mydriatic retinography; and air-puff tonometry. Ophthalmologists working in the central unit evaluate the results immediately after data collection. All clinical information is displayed on private diagnostic workstations. Each workstation is equipped with three screens, so that the ophthalmologist can simultaneously see the video livestream and retrieve all acquired patient data, including numerical topometric data and ocular images ([Fig 2](#pone.0231034.g002){ref-type="fig"}). By means of a telepresence system equipped with high-resolution robotic cameras, the ophthalmologist performs real-time refraction tests and other examinations, such as inspection of the eyelids, tests of extraocular motor function, and pupillary reflexes. The specialist remotely controls a digital refractor and a visual acuity screen through a closed network to perform the refraction tests, to determine the need for corrective eyewear and the power of the corrective lens to be prescribed for the patient.

![Ophthalmologist interacting with patient through livestream video while performing a refraction test.\
The screen on the right is displaying ocular images of the same patient.](pone.0231034.g002){#pone.0231034.g002}

The ophthalmologist then issues a final report to the PCP through the platform. The report describes exam results, provides a diagnosis, and offers clinical recommendations. These recommendations are important for conditions that can be managed in the primary-care setting, such as RE, hordeolum, blepharitis, and mild dry eye. Should the patient need corrective glasses, they are provided free of charge within the project. Conversely, sight-threatening conditions prompt immediate referral; in such cases, the patient is given high priority for an in-person ophthalmological appointment. In this way, the PCP is responsible for decisions on how to manage the patient's case, supported by the ophthalmologist's report. During examinations at *TeleOftalmo*'s remote unit, the nursing staff and ophthalmologists do not provide, directly to patients, diagnoses or treatments necessary for their case.

Statistical analysis {#sec013}
--------------------

A descriptive analysis of patients' characteristics, complaints, and diagnoses was carried out. PASW Statistics, Version 18.0, was used for descriptive and statistical analyses. The chi-square test was used to compare proportions in each age and diagnosis group. Data are presented as numbers (percentage), except for age (mean ± standard deviation).

Ethical aspects {#sec014}
---------------

The institutional review board of Hospital de Clínicas de Porto Alegre approved the research project. We obtained written consent from all patients or, if underaged, from parents or guardians.

Results {#sec015}
=======

During the study period, 8,142 patients completed a *TeleOftalmo* evaluation and had a corresponding report issued by the ophthalmologist to the PCP through the platform. Patient characteristics and demographics are presented in [Table 1](#pone.0231034.t002){ref-type="table"}.

10.1371/journal.pone.0231034.t002

###### Demographic characteristics of the study population: The first 14 months of *TeleOftalmo* project (n = 8,142).

![](pone.0231034.t002){#pone.0231034.t002g}

  ---------------- ----------------------------- ---------------
  **Age, years**   Mean ± SD                     47.99 ± 19.03
  ** **            Range                         8--96
  **Age groups**   Children (\<12 years)         428 (5.3)
  No. (%)          Teenagers (13--17 years)      497 (6.1)
                   Young adults (18--39 years)   1,336 (16.4)
                   Adults (40--64 years)         4,284 (52.6)
                   Older adults (≥65 years)      1,597 (19.6)
  **Gender**       Female                        5,497 (67.5)
  No. (%)          Male                          2,645 (35.5)
  **Ethnicity**    European                      6,290 (77.6)
  No. (%)          African                       545 (6.7)
                   Indigenous                    16 (0.2)
                   Asian                         29 (0.4)
                   Mixed                         1,259 (15.5)
  **Diabetes**     Yes                           1,157 (14.2)
  No. (%)          No                            6,985 (85.8)
  ---------------- ----------------------------- ---------------

The overall resolution capacity of the *TeleOftalmo* strategy was 70.6% (5,748 of 8,142 patients). When stratified into age groups, capacity ranged from 43.1% (older adults) to 89.7% (teenagers). The proportion of solved cases among older adults was significantly lower than in the other age brackets (p\<0.001). [Fig 3](#pone.0231034.g003){ref-type="fig"} presents the results across all ages. Data of 33 individuals were missing and they were excluded from the analysis.

![Resolution capacity of the *TeleOftalmo* strategy across different age groups (p\<0,001).\
Pearson\'s chi square adjusted residuals indicated higher proportion of resolution for children, teenagers, young adults, and adults; and lower proportion of resolution for older adults. Numbers in bars express percentage.](pone.0231034.g003){#pone.0231034.g003}

The single most prevalent condition was any RE (myopia, astigmatism, and hyperopia), which accounted for 70.3% of all diagnoses. [Table 2](#pone.0231034.t003){ref-type="table"} presents the resolution capacity according to reported ocular conditions. Resolution capacity was significantly higher in cases of RE, presbyopia, spasm of accommodation and lid disorders than in patients diagnosed with any other ocular condition (p\<0.001). Patients with diabetic retinopathy, retinal vascular occlusion, and glaucoma or glaucoma suspect needed ophthalmology referral frequently.

10.1371/journal.pone.0231034.t003

###### Resolution capacity of the *TeleOftalmo* strategy across diagnoses from the tele-eye reports.

Pearson\'s chi square adjusted residuals indicated higher (◆) and lower (\*) proportion of resolution for each condition, except for hypertensive retinopathy. Each patient might have more than one diagnosis.

![](pone.0231034.t003){#pone.0231034.t003g}

  Diagnosis                               Number of diagnosis   Prevalence   Resolution capacity   P (Chi-square)
  --------------------------------------- --------------------- ------------ --------------------- ----------------
  Refractive error                        5710                  70,3%        76,5%                 \<0,001 ◆
  Presbyopia                              4571                  56,3%        75,4%                 \<0,001 ◆
  Strabismus                              82                    1,0%         43,2%                 \<0,001 \*
  Spasm of accommodation                  51                    0,6%         90,2%                 0,002 ◆
  Lid disorders                           540                   6,6%         77,6%                 \<0,001 ◆
  Conjunctival disorders                  382                   4,7%         56,3%                 \<0,001 \*
  Cataracts                               1011                  12,4%        24,9%                 \<0,001 \*
  Suspected glaucoma                      617                   7,6%         7,7%                  \<0,001 \*
  Glaucoma                                100                   1,2%         6,0%                  \<0,001 \*
  Nonproliferative diabetic retinopathy   244                   3,0%         21,7%                 \<0,001 \*
  Proliferative diabetic retinopathy      50                    0,6%         12,0%                 \<0,001 \*
  Hypertensive retinopathy                91                    1,1%         62,2%                 0,08
  Retinal vascular occlusion              23                    0,3%         4,3%                  \<0,001 \*
  Others                                  1486                  18,3%        55,4%                 0,001 \*

Diabetic patients accounted for 14.2% of the population (1,157 of 8,142 patients). Resolution capacity was 53.1% among diabetic patients and 73.5% among non-diabetic patients (p\<0.001), explained by a higher prevalence of eye conditions that required referral among diabetic patients: cataracts (20.5% in diabetics vs. 11.1% in non-diabetics, p\<0.001), diabetic retinopathy (17.0% vs. 0.7%, p\<0.001), and suspected glaucoma (11.0% vs. 7.0%, p\<0.001).

Discussion {#sec016}
==========

In our series, resolution capacity was around 70%; that is, 70% of all patients that would have been placed on a waiting list for ophthalmologist referral without the *TeleOftalmo* strategy were successfully managed in primary care instead. Consequently, we expect to have a significant impact on waiting times for ophthalmological treatment as the project scales up. Attempts to reduce waiting times with the use of telemedicine have already shown good results in Scotland. \[[@pone.0231034.ref011]\] Following the recommendations of the United Kingdom short waiting-time guidelines for outpatient appointments, the referral pathway was modified with the use of a fully electronic ophthalmic-referral service with digital imaging. The use of a centralized unit that interprets eye images for clinical decision-making prevented the need for appointment in 37% of referrals. \[[@pone.0231034.ref011]\] Our resolution capacity was higher than that of this study, probably due to the fact that we offered a comprehensive eye exam rather than eye imaging only. Additionally, it is important to note that our tele-eye exam aims at patients that do not have a clear indication for referral; patients already diagnosed with any eye disease that requires treatment are directly referred to tertiary centers, as described in our exclusion criteria. The selection criteria imply that the resolution capacity observed applies only to the population enrolled in the project and would not be as high if the whole waiting list for ophthalmology care were considered.

The lowest resolution capacity was found among older adults (age ≥65 years). Ocular aging is a known risk factor for several diseases, such as cataract, glaucoma, and age-related macular degeneration. \[[@pone.0231034.ref012],[@pone.0231034.ref013]\] As expected, the prevalence of these conditions was higher among older people in our sample. The advantages of diagnosing conditions that cannot be treated in primary care are to enable straightforward referrals to specialty centers (for example, cataract patients to cataract surgery centers) and to prioritize more severe cases on the waiting list. In some conditions, establishing the diagnosis ahead of a conventional in-person visit may also allow the patient to benefit from modification of risk factors, such as improving glycemic control in diabetic patients once they are diagnosed with diabetic retinopathy.

In this study, RE was the most prevalent condition. This is consistent with the literature, in which refraction problems and presbyopia are the main reported reasons for seeking eye care. \[[@pone.0231034.ref014]\] Uncorrected RE is a major cause of moderate to severe vision impairment in low- and middle-income regions. \[[@pone.0231034.ref015]\] Nevertheless, greater emphasis has historically been placed on eye diseases rather than on refractive problems, both in health policy and in research. \[[@pone.0231034.ref016],[@pone.0231034.ref017]\] Within the *TeleOftalmo* paradigm, refraction tests are part of telemedicine-based comprehensive eye exams offered in primary care units. This allows patients to remain in the community and avoids long waits for specialty referral to address visual deficits due to simple RE. It bears stressing that, in Brazil, ophthalmologists are the professionals in charge of performing refraction tests and prescribing corrective eyewear. Ophthalmological services are highly concentrated in tertiary care centers, unevenly distributed across the country, and any eye complaint would require referral from primary care to a specialist. Patients with RE are placed on the same waiting list as those with undiagnosed, progressive eye diseases. The aim of *TeleOftalmo* was to alleviate the large, growing demand for specialist ophthalmologist care and to diagnose eye conditions sooner than if patients had waited for an in-person visit to a specialist. As many eye conditions can be treated in primary care once properly diagnosed, it is well established that consultant ophthalmologists can assist primary care physicians through telemedicine. \[[@pone.0231034.ref018]--[@pone.0231034.ref020]\] Second, this strategy fast-tracks patients with sight-threatening diseases that would otherwise have their treatment delayed. Glaucoma and retinal diseases, for instance, may lead to permanent vision loss without timely treatment.

To our knowledge, this is the first teleophthalmology program in the world that performs real-time subjective refraction, and the first one in Brazil that offers comprehensive eye exams. Most of the prior initiatives have focused on a model of forwarding fundus photographs for remote reading, with effective results for detecting some specific diseases. \[[@pone.0231034.ref021]--[@pone.0231034.ref023]\] These initiatives are usually intended to screen a specific disease in a high-risk population--for instance, diabetic retinopathy in diabetic patients \[[@pone.0231034.ref024],[@pone.0231034.ref025]\] and retinopathy of prematurity in premature newborns. \[[@pone.0231034.ref026],[@pone.0231034.ref027]\] The *TeleOftalmo* project, on the other hand, is dedicated to comprehensive eye-checks and providing glass prescription. This is particularly important in our setting due to unmet demand for ophthalmological visits, as discussed above.

Adequate IT infrastructure is critical for telemedicine. To achieve *TeleOftalmo*'s purposes, it was necessary to develop specific workflows and an integrated data system that covered the entire pathway from the tele-eye request to the final report. By the time the project was implemented, there was no off-the-shelf system that would provide the adequate networking between the requesting PCP, the assistant team that verifies if the patient meets the study criteria and schedules the exams, the nursing team at the remote units, and the remote ophthalmologists. The system not only had to manage health data securely, but it also should follow the clinical steps we planned, which includes an initial asynchronous data acquisition, followed by medical review and hypothesis formulation, synchronous medical examination and final tele-eye report. By developing our own telehealth platform, these needs were met.

Interoperability of medical equipment and systems is another issue we tackled. Although there have been significant improvements in healthcare IT, it is still a complex and intricate task to integrate practice management system, electronic health records (EHR), and eye care equipment.\[[@pone.0231034.ref028]\] Interoperability represents the ability of systems and devices to easily exchange data, regardless of the vendor or brand. \[[@pone.0231034.ref028]\] Since most ophthalmic device outputs are still in a proprietary format and cannot be readily imported into an EHR \[[@pone.0231034.ref010]\], it has been a central part of our project to overcome these issues. Interoperability minimizes the risk of patient misidentification and reduces technicians' working time, since repetitive data entry is no longer necessary. \[[@pone.0231034.ref029]\] It may also contribute to the remote ophthalmologist's productivity, given that all images and test results are readily available from the same server and retrieved in one single viewer.

Other experiences with teleophthalmology reported in the literature have used the primary care setting as well, in order to provide patients with the opportunity to receive eye care via telemedicine as part of their routine visit. \[[@pone.0231034.ref030]\] In Atlanta, Georgia, a program called Technology-Based Eye Care Services (TECS) was established in 5 primary care clinics, where technicians were trained to collect information about the patient's eyes. \[[@pone.0231034.ref031]\] The information then is interpreted remotely, and patients with possible abnormal findings are scheduled for a face-to-face examination. TECS and TeleOftalmo share many common features: they are teleophthalmological services based in primary care facilities, provide comprehensive eye-checks, and ocular diseases prompt an in-person exam. However, *TeleOftalmo* makes use of real-time virtual encounters between patient and ophthalmologist. These encounters allow the ophthalmologist to interact with the patient and perform subjective refraction. Based on trial and error and patient collaboration, subjective refraction warrants the best refinements in the prescription of glasses. Other tests are possible to be performed through our high-resolution robotic cameras, such as inspection of the eyelid position and function, extraocular motor function, and pupillary reflexes. Therefore, the differential of *TeleOftalmo* is the use of real-time interactive telemedicine and remotely operated equipment. These features may have contributed to the case-solving capacity reported in this study.

Conclusion {#sec017}
==========

We report the results of a novel telemedicine project that supplements primary care with telediagnosis in ophthalmology in a limited-resource country. Offering diagnostic through telemedicine allows more precise identification of patients with sight-threatening diseases, who need prompt referral to an ophthalmologist and, conversely, cases that are well suited for primary care management. Over two-thirds of our sample could be managed at the primary care level with the aid of a remote consultant ophthalmologist. The strategy had a higher resolution capacity for patients under the age of 65 who presented with refractive error and/or presbyopia. By incorporating regular use of teleophthalmology in the primary care setting as part of the workup of patients with eye complaints, we expect to achieve a more effective use of specialty centers, whose limited capacity enforces a limit on the number of patients that can be seen in person.

10.1371/journal.pone.0231034.r001
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1\. The p-values should be linked to presented tables to visualize significance (e.g.: new column for p-value or 95%CI).

2\. Were assumptions fulfilled in case of Chi-squared test for each strata? (at least 5 obs in 80% of all cells)

Regards,

Reviewer \#2: This paper presents experimental results regarding a teleophthalmology system

implemented in the public health system of southern Brazil. The aim of the work

was to measure up the ability of the system to fully address patients' eye complaints

in primary care with remote assistance from ophthalmologists.

The purpose of the action is clear and currently an important field; the manuscript

is well-written and easy to follow from these aspects. The study is well-prepared and

the evaluation has been performed convincingly with some positive outcome regarding

the benefits of applying the system in health care.

In general, I think that the results are reasonable and interesting for a wide

\-- also scientific \-- audience. My greatest concern that should be resolved to

propose the publication of the paper is a much deeper comparison with other

existing teleophthalmology systems; some such effort has been made in the manuscript,

but I definitely suggest widening this study. Especially, the methodological contribution

could be emphasized more with highlighting any clinical/technological (IT) considerations

that makes the system competitive or superior comparing with other solutions.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0231034.r002

Author response to Decision Letter 0
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Journal Requirements:

1\) When submitting your revision, we need you to address these additional requirements.

a\. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.

b\. A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.

c\. An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Response: These files were provided.

2\) Please state in your methods section whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB approved the lack of parent or guardian consent.

Response: We have now included the information in Methods.

3\) We note that Figure(s) 1 in your submission contain \[map/satellite\] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth).For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth).

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission.

Response: Figure 1 contains a map that was designed by our Department\'s designers, based on publicly available maps from Brazil. They did not use proprietary data or softwares, such as Google Maps. As such, we would keep the figure, but if the Editor recommends otherwise, we can remove it.

Comments to the Author

Reviewer \#1:

Dear Authors,

In my opinion, the paper is well written and contributes to the existing knowledge. I could not find any logical errors in the presentation and the approaches used.

I have provided my comments/questions for consideration:

1\. The p-values should be linked to presented tables to visualize significance (e.g.: new column for p-value or 95%CI).

Response: We thank you for the opportunity to review this point. We added the p-values in table 2 and figure 3. Regarding the table 2, after reviewing the manuscript, we have changed its presentation to provide more information on resolution capacity of the teleophthalmology program.

The previous table 2 was intended to describe the prevalence of diagnoses across all age groups, but not to directly compare them. If the editors and/or reviewers still find informative to present this table, we can paste it as supplementary material.

2\. Were assumptions fulfilled in case of Chi-squared test for each strata? (at least 5 obs in 80% of all cells).

Response: Yes, they were. As mentioned above, we changed the presentation of results and now Chi-square results (including p-values and adjusted residuals) are more explicit.

Reviewer \#2: This paper presents experimental results regarding a teleophthalmology system implemented in the public health system of southern Brazil. The aim of the work was to measure up the ability of the system to fully address patients' eye complaints in primary care with remote assistance from ophthalmologists.

The purpose of the action is clear and currently an important field; the manuscript is well-written and easy to follow from these aspects. The study is well-prepared and the evaluation has been performed convincingly with some positive outcome regarding the benefits of applying the system in health care.

In general, I think that the results are reasonable and interesting for a wide \-- also scientific \-- audience. My greatest concern that should be resolved to propose the publication of the paper is a much deeper comparison with other

existing teleophthalmology systems; some such effort has been made in the manuscript, but I definitely suggest widening this study. Especially, the methodological contribution could be emphasized more with highlighting any clinical/technological (IT) considerations that makes the system competitive or superior comparing with other solutions.

Response: Thank you for giving us the opportunity to increase the quality of our report. We included a detailed description of IT developments for this project in the Methods section, under The TeleOftalmo System subsection. In Discussion, we now have explored these developments and the associated clinical workflow in-depth. We also have compared our work to other primary-care based teleophthalmological programs - in summary, the differential of TeleOftalmo is that we offer a comprehensive eye exam, instead of screening only for specific diseases, and that we use real-time interactive telemedicine and remotely operated equipment.
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PONE-D-19-24060R1

The use of telemedicine to support Brazilian primary care physicians in managing eye conditions: the TeleOftalmo Project

PLOS ONE

Dear Dr MOREIRA,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please make the requested minor modification and than we would appreciate receiving your revised manuscript by Mar 26 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Adrienne Csutak, MD, PhD, MSc

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#3: The manuscript describes a study of a telemedicine application to ophthalmology. The purpose was to show the extent that tele-ophthalmology as practiced by the authors can distinguish between cases requiring referral to an ophthalmologist versus cases that can be managed at the primary care level, which potentially is of interest to communities with certain limited resources.

The authors have responded properly to the previous reviewers' comments and questions. In the present form of the manuscript, the treatment of the data is appropriate, the amount of detail is sufficient, and the figures and tables are acceptable. However, in the originally submitted manuscript, there was a line item in Table 2 for 'accommodation disorder' that is absent in the revised Table 2. The authors should correct this omission before publication.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: Yes: David M Silver

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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6\. Review Comments to the Author

Reviewer \#3: The manuscript describes a study of a telemedicine application to ophthalmology. The purpose was to show the extent that tele-ophthalmology as practiced by the authors can distinguish between cases requiring referral to an ophthalmologist versus cases that can be managed at the primary care level, which potentially is of interest to communities with certain limited resources.

The authors have responded properly to the previous reviewers' comments and questions. In the present form of the manuscript, the treatment of the data is appropriate, the amount of detail is sufficient, and the figures and tables are acceptable. However, in the originally submitted manuscript, there was a line item in Table 2 for 'accommodation disorder' that is absent in the revised Table 2. The authors should correct this omission before publication.

RESPONSE:

Thank you for catching this missing condition. We have now added the missing condition to Table 2, under the name "Spasm of accommodation". The term "spasm of accommodation" was used instead of "accommodation disorder" in order not to be confused with presbyopia.
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Dear Dr. MOREIRA,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Adrienne Csutak, MD, PhD, MSc

Academic Editor

PLOS ONE
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PONE-D-19-24060R2

The use of telemedicine to support Brazilian primary care physicians in managing eye conditions: the *TeleOftalmo* Project

Dear Dr. MOREIRA:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Adrienne Csutak

Academic Editor

PLOS ONE
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